Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (21-30 of 434) with videos related to

Pageof 44
Sort By:
Arthritis Care & Research|March 18, 2010
Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysisMichael Walsh, Peter A Merkel, Alfred Mahr, et al.
Rheumatology (Oxford, England)|May 21, 2009
Assessment of damage in vasculitis: expert ratings of damagePhilip Seo, David Jayne, Raashid Luqmani, et al.
Journal of Inflammation Research|September 16, 2022
ANCA Associated Vasculitis Subtypes: Response [Letter]Peter A Merkel, David R W Jayne, Pirow Bekker
BMC Medical Informatics and Decision Making|September 27, 2014
Variability of the impact of adverse events on physicians' decision makingRaluca Cozmuta, Peter A Merkel, Elizabeth Wahl, et al.
Arthritis Care & Research|July 23, 2014
Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and HealthNataliya Milman, Annelies Boonen, Peter A Merkel, et al.
JAMA|October 19, 2021
Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated VasculitisDavid R W Jayne, Peter A Merkel, Pirow Bekker
Critical Care Clinics|June 11, 2002
Evaluation and treatment of vasculitis in the critically ill patientPeter A Merkel, Hyon K Choi, John L Niles
The New England Journal of Medicine|May 27, 2021
Avacopan for the Treatment of ANCA-Associated Vasculitis. ReplyDavid R W Jayne, Peter A Merkel, Pirow Bekker
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2017
ReplyCarol A Langford, Jeffrey P Krischer, Peter A Merkel, et al.
The New England Journal of Medicine|May 28, 2020
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. ReplyMichael Walsh, Peter A Merkel, David R W Jayne
Pageof 44

Showing results (21-30 of 434) with videos related to

Sort By:
Pageof 44
Arthritis Care & Research|March 18, 2010
Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysisMichael Walsh, Peter A Merkel, Alfred Mahr, et al.
Rheumatology (Oxford, England)|May 21, 2009
Assessment of damage in vasculitis: expert ratings of damagePhilip Seo, David Jayne, Raashid Luqmani, et al.
Journal of Inflammation Research|September 16, 2022
ANCA Associated Vasculitis Subtypes: Response [Letter]Peter A Merkel, David R W Jayne, Pirow Bekker
BMC Medical Informatics and Decision Making|September 27, 2014
Variability of the impact of adverse events on physicians' decision makingRaluca Cozmuta, Peter A Merkel, Elizabeth Wahl, et al.
Arthritis Care & Research|July 23, 2014
Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and HealthNataliya Milman, Annelies Boonen, Peter A Merkel, et al.
JAMA|October 19, 2021
Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated VasculitisDavid R W Jayne, Peter A Merkel, Pirow Bekker
Critical Care Clinics|June 11, 2002
Evaluation and treatment of vasculitis in the critically ill patientPeter A Merkel, Hyon K Choi, John L Niles
The New England Journal of Medicine|May 27, 2021
Avacopan for the Treatment of ANCA-Associated Vasculitis. ReplyDavid R W Jayne, Peter A Merkel, Pirow Bekker
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2017
ReplyCarol A Langford, Jeffrey P Krischer, Peter A Merkel, et al.
The New England Journal of Medicine|May 28, 2020
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. ReplyMichael Walsh, Peter A Merkel, David R W Jayne
Pageof 44